New York State Common Retirement Fund Savara Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Savara Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,855 shares of SVRA stock, worth $44,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,855
Previous 30,739
54.93%
Holding current value
$44,197
Previous $124,000
52.42%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SVRA
# of Institutions
129Shares Held
158MCall Options Held
72.4KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$78.1 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$46.5 Million11.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$39.4 Million6.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.62MShares$27.5 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$26 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $364M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.